Serum KL-6 a better predictor of progressive SSc-ILD than CYFRA 21-1
A recent study has found that serum KL-6, a mucin-like glycoprotein (MUC1) expressed by type II pneumocytes, is associated with decline in lung function in systemic sclerosis (SSc), indicating its clinical utility in risk stratification for progressive SSc-related interstitial lung disease (ILD).